Company EURO BIOT

Equities

EBAC

KYG3167F1028

Market Closed - Nasdaq Other stock markets 10:32:06 17/05/2024 pm IST			5-day change	1st Jan Change
11.98 ^USD	+0.04%		+0.04%	+7.02%

2023	European Biotech Acquisition Corp.(NasdaqCM:EBAC) dropped from NASDAQ Composite Index	CI
2023	Oculis SA completed the acquition of European Biotech Acquisition Corp. from Lsp Sponsor Ebac B.V. and others in a reverse merger.	CI

Business Summary

European Biotech Acquisition Corp is a blanc check company based in the Netherlands. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to primarily seek to identify a company within the European life sciences industry. The aim of the Company is investments in therapeutic drug candidates in clinical development across a range of therapeutic areas, including oncology, diabetes, cardiology, central nervous system (CNS) and orphan diseases.

Company contact information

European Biotech Acquisition Corp.

EPFL Innovation Park Building

1015, Lausanne

+31 20 664 55 00

http://www.lspvc.com/ebac

Sector

This company's sector is not yet available